食管癌是常见的消化道恶性肿瘤。我国的食管癌发病率、死亡率居世界之首[1]。由于早期食管癌无特殊临床表现,大多数食管癌患者就诊时己处于中晚期,失去了根治性手术切除的机会,5年生存率较低。为了提高食管癌患者的治疗疗效,国内外学者进行了各种治疗研究。现将化疗在食管癌综 Esophageal cancer is a common malignant tumor of the digestive tract. The incidence and mortality of esophageal cancer in China ranks first in the world [1]. Due to the lack of special clinical manifestation of early esophageal cancer, most esophageal cancer patients have been in advanced stage at the time of treatment, and they have lost the chance of radical surgical resection and have a low 5-year survival rate. In order to improve the therapeutic efficacy of patients with esophageal cancer, scholars at home and abroad have conducted various therapeutic studies. Current chemotherapy for esophageal cancer